<DOC>
	<DOCNO>NCT01606605</DOCNO>
	<brief_summary>The investigator perform retrospective microarray gene expression profile study FFPE cohort DLBCL patient whole genome cDNA mediate Annealing Selection Ligation ( WG-DASL ) assay . The investigator also study pattern microRNA patient diffuse large B-cell lymphoma . The result gene expression profile microRNA correlate clinical outcome diffuse large B-cell lymphoma .</brief_summary>
	<brief_title>Treatment Resistance Related With Gene Expression Profile Diffuse Large B-cell Lymphoma</brief_title>
	<detailed_description>1 . Whole genome cDNA mediate Annealing Selection Ligation ( WG-DASL ) assay - Diffuse large B-cell lymphoma patient - Paraffin-embedded tissue - End point : Progression-free survival , overall survival - Statistics : Leave one-out method 2 . Nano string assay microRNA - Diffuse large B-cell lymphoma patient - Paraffin-embedded tissue - End point : Progression-free survival , overall survival - Statistics : Leave one-out method</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<criteria>Patients diagnose diffuse large Bcell lymphoma Patients tissue block available study Patients adequate medical record Patients diagnose subtypes lymphoma</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Lymphoma</keyword>
	<keyword>Prognosis</keyword>
	<keyword>Relapse</keyword>
	<keyword>Gene</keyword>
	<keyword>microRNA</keyword>
</DOC>